Results for:(13 found)
May 5, 2014 3:44PM on Top StocksBy MSN Money Partner

Some say the Nasdaq looks nothing like it did in the dot-com days. Here are some points to consider.

Sep 5, 2013 10:56AM on Top StocksBy TheStreet Staff

Because competitors' drugs failed, expectations are low for the pharmaceutical's BACE inhibitor, which may help the stock.

Aug 21, 2013 12:13PM on Top StocksBy MSN Money Partner

Stocks are lower as buyers sit on the sidelines ahead of the release of the minutes from the last FOMC meeting.

Mar 18, 2013 1:56PM on Top StocksBy MSN Money Partner

Stocks are lower after the proposed terms of a bailout for Cyprus re-ignite fears about the financial situation in that nation and the other members of the EU.

Jan 24, 2013 11:55AM on Top StocksBy Stock Traders Daily

A pharmaceutical takeover rumor is in the air.

Jan 23, 2013 12:26PM on Top StocksBy MSN Money Partner

Ford is downgraded to 'hold,' and Novartis is upgraded to 'buy.'

Dec 12, 2012 2:38PM on Top StocksBy Minyanville.com

The $510 million acquisition of YM BioSciences is a low-risk deal for the big biotech, and has Incyte shareholders worried.

Tags: GILDINCY
Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More